Mohammad Jahanzeb, MD, medical director, Sylvester Comprehensive Cancer Center at Deerfield Beach, talks about the future of treatment for patients with HER2-positive breast cancer with drugs like neratinib and trastuzumab.
Mohammad Jahanzeb, MD
Articles by Mohammad Jahanzeb, MD
Latest Updated Articles
Dr. Mohammad Jahanzeb on Neratinib and Trastuzumab in HER2-Positive Breast CancerPublished: November 19th 2015 | Updated: